Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01215240
Other study ID # 2010-LR-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2010
Est. completion date December 2013

Study information

Verified date August 2019
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Babies born with hypoplastic left heart syndrome (HLHS) have three separate, complex heart surgeries before they turn three years of age. The first surgery typically happens in the first two weeks of life. After this operation, babies come back to the intensive care unit with their chests open. Babies who have heart surgery retain body water after surgery and this extra water slows recovery. Surgeons cannot close the chest until the baby gets rid of the extra water. As a result, babies have to stay in the intensive care unit and on a breathing machine for longer.

Peritoneal dialysis, also known as PD, involves placing a small catheter into the belly cavity at the time of surgery. PD helps the kidney to get rid of extra body water. PD involves putting small amounts of special fluid into the belly through the catheter. This special fluid attracts water and is drained hourly. By allowing the belly cavity to drain, this helps both the heart and the lungs. This allows the chest to be closed and the breathing tube to be removed. The investigators are looking to see how quickly the babies, with and without PD, get rid of the extra water in turn shortening their stay in the intensive care unit and in the hospital. PD is not permanent, and only used for the first few days after the operation.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date December 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender All
Age group N/A to 30 Days
Eligibility Inclusion Criteria:

- Infants with HLHS or its variants who have a Norwood procedure

- Parental consent

Exclusion Criteria:

- Premature neonates less than 37 weeks gestation

- Weight less than 2 kg

- Urine output less than 0.5ml/kg/hr over 24 hours in the 48 hours prior to the Norwood

- Pre-operative renal replacement therapy

- Abdominal defects precluding placement of a PD catheter

- Known chromosomal abnormality

- Pre-operative cardiopulmonary resuscitation (CPR)

- Pre-operative extra-corporeal life support (ECLS)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Peritoneal dialysis
Prophylactic peritoneal dialysis

Locations

Country Name City State
Canada Stollery Children's Hospital Edmonton Alberta

Sponsors (2)

Lead Sponsor Collaborator
University of Alberta Women and Children's Health Research Institute, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to First Post-operative Negative 24 Hour Fluid Balance Time to first post-operative negative fluid balance which occurred in first 72 hrs up to 72 hours
Secondary Time to Sternal Closure Up to 200 hours
Secondary Time to Lactate Less Than or Equal to 2mmol/L Time to lactate less than or equal to 2mmol/L typically occurred in first 24 hrs From time of admission in PICU until assessment was reached, assessed up to 24 hours
Secondary Time to First Extubation Up to 15 days
Secondary Maximum Vasoactive Inotrope Score (VIS) on Post-operative Days 2-5 The maximum VIS assessed from days 2-5 will be chosen. A total VIS score is reported; there are no subscales. Minimum VIS is 0 (there are no units to VIS). Maximum VIS could be 100 but numbers are more typically 5-40. Higher VIS represent more inotropic support and potentially worse outcomes. Assessed at days 2, 3, 4 and 5 with the highest score from those 4 days reported
Secondary Hospital Length of Stay Assessed up to 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT00513240 - Erythropoetin Neuroprotection for Neonatal Cardiac Surgery Phase 1/Phase 2
Withdrawn NCT00156455 - Sleep Disordered Breathing in Children With Single Ventricle Physiology N/A
Terminated NCT01445041 - Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome Phase 1
Recruiting NCT04581668 - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease N/A
Completed NCT01736956 - Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome N/A
Completed NCT01708863 - A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
Recruiting NCT03406884 - The CHILD Trial: Hypoplastic Left Heart Syndrome Study. Phase 1
Not yet recruiting NCT06461676 - Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS) Phase 1
Active, not recruiting NCT03079401 - Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle Phase 1/Phase 2
Completed NCT02306057 - Fluid Balance in Children Undergoing Fontan Surgery N/A
Terminated NCT01107990 - Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Completed NCT01883076 - Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome Phase 1
Completed NCT04056416 - Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike) N/A
Completed NCT01656941 - Genetic Determinants of Congenital Heart Disease Outcomes
Completed NCT00464100 - Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
Active, not recruiting NCT03779711 - Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome Phase 2
Recruiting NCT04925024 - Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. Phase 2
Recruiting NCT02781922 - Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial) Phase 3
Completed NCT01582529 - SVRII Family Factors Study
Completed NCT00974025 - Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients N/A